Shesa's NOVEMBER 2025 Investment Blog

Welcome to Shesa’s Blog

U.S. Stock Market Update 

I have a shorter version of my blog this month. The month of October started in a volatile manner but it picked up and Dow was up 2.6%, S&P 500 was up 2.3% and Nasdaq roared up 4.7%. We are seeing the similar trend in the month of November. Historically, November happens to be the best month for the stock market since 1950. As of date, Nasdaq is up 21.5% and S&P 500 is up 16.4% for the year. Meanwhile, the stock market had a volatile week on the fear of AI/tech valuation, longest government shutdown in U.S history. It’s expected to end tomorrow, let’s see if that happens. The ADP payroll was little better but layoffs in October (153,074) the highest in last 23 years mostly attributed to cost cutting due to AI impact and DOGE impact. The consumer sentiment was second lowest ever due to government shutdown and dull labor market situation. Despite strong Q3 earnings (82% beats, ~11% growth) the stock market has not been able to rally strongly due to the aforesaid facts.  But last week Nasdaq had one of the worst week since April 2025. 

The AI investments by the corporate world continues to go up. In the current quarter, the following spending are planned by big techs:

Amazon: $35B, Google: $24B, Microsoft: $19.4B, META: $18.8B and Apple: $3.24B.

But Wall Street is concerned that the tech companies are not over investing and what would be the future return on investment. These are valid concern and as a matter of fact, the technology stocks were down significantly last week and on Tuesday. The market has started rotating some money to the DOW stocks like healthcare from technology stock. But in my view, are temporary phenomena which we keep seeing often. Hence, I feel that these may be the opportunity for accumulation. I also think that the bullish momentum into year-end should continue, but high valuations risk concern may be brought by Wall Street to scare the retail investors. The biggest earnings of the season will come soon when Nvidia (NVDA) reports earnings on 11/19. If earnings are good, this may ignite further rally into the year end. 

Federal Reserve

The federal reserve cut 0.25% interest rate on October 29 bringing the rate down to 4%.  The next Fed Meeting is expected on December. J Powell said, December cut is not given. However, I do feel that FED would cut another 0.25% interest rate next month visualizing the tight labor market.

My thoughts

Despite the current market pullback in the tech stocks we should be a good rally to end the year. Historically, November and December are good month for the stock market, and November being one of the best. We will see if that changes this year. Hence, it may be an opportunity to accumulate on the pullback. Reminding the readers that historically November, December and January are the best 3 months for the stock market. Nothing is written on the stone but my expectation is we should see some rallies before the end of the year. Let’s see the stock market indexes:

Indexes	Close TUE 12/30/24	Close TUE 11/11/25	Change in 2025	% Change in 2025
DOW	42,544.22	47,927.96	5,383.74	12.65
S&P 500	5,881.63	6,846.61	964.98	16.41
NASDAQ	19310.79	23,468.30	4,157.51	21.53
Russel 2000	2,230.16	2,458.28	228.12	10.23
SOX (Semi)	4,979.93	6,979.70	1,999.77	40.16

Why do I keep saying Tesla (TSLA) is a good longterm Investment?

Tesla (TSLA): More than a year ago, I told about AI and QC and now I will be watching Tesla for next 3-5 years. If we think Tesla is a EV company and invest then potentially we may miss great future potential. I told similar stuff when Nvidia (NVDA) came with AI momentum. The skeptics either do not like Elon Musk or they don’t like Tesla Car. But as I always say I am a growth investor and put my money where money can be made now or in future. The shareholders approved $1T package for Elon Musk, but he gets only when he is able to meet several milestones. I wrote a few times in my WhatsApp group about it. Musk gets his $1T package in a phased manner and will get the whole $T only when Tesla Market Cap reaches to about $8.5T. If so, the Tesla stock would be trading about $3,000 from current $430. I will be more than interested in investing who gives me such huge return on investment (ROI). It’s extremely tough task, but never write-off Elon Musk. He may be little late in delivering but mostly he has delivered when most of the Wall Street experts thought those were unachievable. Having said that, this stock may be wild ride sometime and we have to live with that. If we are not comfortable in such moves then better to stay away. But not having Tesla in our portfolio may not be a good idea, if we are a long term investor. Rest is our own due diligence and can’t emphasize more. I may be wrong but I strongly believe on the future of this company. So, why I am so confident? First of all, Tesla isn't just building robots. They're orchestrating a silent revolution. You might have heard the phrase the "iPhone moment" before, I'm sure most of us do...With one launch, Apple changed everything... created an entirely new kind of product... and set off a massive bull market. Apple (AAPL) itself rose more than 6,000% in the wake of the iPhone moment, becoming the world's first $4 trillion company in the process.

Tesla Catalysts for 2026

New Tesla products that start shipping in 2026:

• Optimus robot (Gen 3): This may potentially be a game changer. It may not happen immediately but the potentially it has  humongous opportunity.
• Cybercab / RoboTaxi: Car without driver. It’s not only the ride for people but also it may have significant impact on the transportation of goods and services. 
• Tesla Semi Truck: production starts in fist half of 2026 and ramps upon the 2nd half in Nevada factory
• Megapack Battery 3: Highly efficient battery storage that would operate in a temperature from -40 degree C to +60 degree C. New residential solar panel.
• Tesla Roadster (affordable EV) production starts in 2027.

My final thoughts: As I said, I have told about this many time since the stock was below $200. I am not saying one should go and invest in Tesla. The whole contention is, I feel it as a compelling long term opportunity. When I told this about NVDA and APPL a few years ago, many people questioned my judgment and felt that I am hyping. Sorry, I have no interest who buys or who doesn't. My job is to express my opinion. At this time I see it as a great long term investment but that’s me. Every one must do their do diligence and invest only if they are comfortable. 

My Strategy in current market environment

There is no change in my strategy. In fact, it’s working well so won’t change anything at this time. But possibly focussing little more on hedging makes sense since market is almost at the pick. If you want to read my strategy, please refer to my September blog. 

Stock Market TOP sectors for 2025 (as of 11/11/25)

Sector	YTD Performance in %age
Communication Services	27.35
Information Technology (TOP)	26.21
Utilities	18.16
Industrials	16.94
Financials	9.86
Consumer Staples (Worst)	1.07

You can click below link to view complete sectorial performances:

Source: https://www.barchart.com/stocks/sectors/rankings?timeFrame=Ytd

Now let me discuss this month’s hedging pick for my Blog Portfolio.

Tempus AI (TEM) 

Tempus AI, is an AI-driven healthcare company. The machine learning analyzes vast clinical molecular data for precision medicine for personalized treatments for patients in Cardiology, Oncology, diagnostic and drug discovery. It provides next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology.

Why do I like TEM?

TEM is one of the fantastic healthcare AI company growing at a faster pace. Let’s see some of the metrics:

• Revenue $334M vs. 328.73M, up 85% YoY, genomics tests +33%, data licensing +26%
• EPS: -0.11 vs. -0.18 expected. Beat.
• FY2025 guidance: $1.265B up 80% vs. $1.24B
• For first-ever positive adj. EBITDA $1.5M (from -$22M). Gross margin 63%
• AI related updates: 350 Peta Byte multimodal data lake comprising of DNA, RNA, pathology, EHR, imaging etc. 
• $200M deal with AstraZeneca/Pathos oncology 
• Minimal Residual Disease (MRD) reimbursement 2026, 40M+ patient records grow 20-30% yearly. AI apps up 150% YoY.
• The company has $764M in cash 

Strategy

As of last Friday, when I added it to my blog portfolio, the stock was trading at $71.56 as of last Friday when I updated my blog portfolio and sent a communication to my WhatsApp group. The 52-week high for this stock is $104.32, down about  -31.4% from its high. The stock has gone up 114% since the beginning of the year. The stock has a P/E ratio 41.5 which is not cheap. But please note that the insiders hold 40.8% of the shares. 

Despite the higher valuations and risks (pls see below), it’s one of the best growth stock in the market visualizing its current growth and future potential . I have been tracking this stock for more than a year and is invested. Despite its solid earnings on November 4, the stock got hammered and I thought this is the right time and opportunity to add to my blog portfolio. I have been accumulating strategically to my current position and keep trimming as the situation demands. As most of my blog readers know, I am  a growth investor and usually I never buy any stock at once. I always buy in small quantities in a phased manner. I also add some options based on its prospects. When the stock goes up, it’s extremely important for me to take some chips out of the table and book some profits. That’s always part of my strategy. Also, TEM is a growth and volatile stock, hence some hedging is important to mitigate/protect from any significant downside. But I may slowly keep accumulating if the stock pulls back further.

Risks

As I said above, obviously it’s not a cheap stock. Its founder has majority stake which can be seen as positive or negative, partnership reliance, regulatory risk and so on. If market goes down further it may fall fast. This stock is advisable only for the growth investors who can absorb volatility. Otherwise, better to stay away. There always a risk with any stock, and more so for the growth stock.

My final thoughts

Tempus AI (TEM) is a growth company in the healthcare sector. It has explosive growth in genomics revenue and expanding AI-driven oncology diagnostics. Though healthcare sector is not doing great there are few companies who doing exceedingly well in this sector and TEM is one of the top performer. It’s also an expensive stock but growth stocks are always like that because they are valued not based on their past performance rather future potential. Having said that, if I see any red flag on any of my holding, then I don’t hesitate to pull the trigger irrespective of how great the company/stock may be. I do NOT fall in love with any stock. So, emotions should not impact my investment decision. At this time, I feel TEM has a great potential, hence I am invested.

Some Key Earnings Updates

CoreView (CRWV)

• Revenue $1.365B (beat est. $1.29B, +134% YoY). Net loss $110M (improved from $360M YoY). 
• EPS loss $0.22. Backlog $55.6B. Key deals: $14.2B Meta, OpenAI expansion.
• My view: The earnings report that exceeded expectations but featured somewhat weak guidance. A delay related to a single data center was the culprit. For the patient investors it’s an opportunity. I am adding on the pullback. 

Nebius Inc (NBIS)

• Revenue $146.1 million, up 355% year over year but fell short of analysts' expectations of $155.7 million. 
• Earnings: net loss widened to $100.4 million from $39.7 million in the prior-year period. T
• My view: The good news is it signed another 5 years AI infrastructure deal with META. The company aims to reach an annualized run-rate revenue of $7- $9 billion by the end of 2026 as new capacity comes online. I think this is one of the best company for the AI infrastructure. I am adding on the pullback. 

Hims & Hers Health (HIMS)

• Revenue: $599 million vs analyst estimates of $579.6 million (49.2% year-on-year growth, 3.3% beat)
• EPS (GAAP): $0.06 vs analyst expectations of $0.11 (43.7% miss
• Guidance for Q4 CY2025 is $615 million at the midpoint, below analyst estimates of $631.6 million
• My view: This stock may have been wounded but I see a great potential for the longterm patient investors. I keep adding on the dip.

Google (GOOG)

• Revenue: $102.35 billion vs. $99.89 billion adj. estimated
• Earnings per share: $2.87 not immediately comparable
• Projections: 2025 capex $91-93B; cloud backlog $155B.
• My View: I guess this is one of the best big 7 stock based on its valuations.

Microsoft (MSFT)

• Revenue: $77.67 billion vs.  $75.33 billion expected, up 18%. Azure revenue up 40%.
• Earnings per share: $4.13 adjusted per share vs. $3.67 per share expected.
• Projections: Capex growth > FY2025 rate; cloud rev. >$75B FY2025.
• My view: I liked to earnings. The pullback is an opportunity to accumulate.

Meta Inc (META)

• Revenue: $51.24B (beat $49.41B est., +22% YoY).
• EPS: $7.25 adj. (beat $6.69 est.). But
• Projections: 2025 capex $70-72B; total expenses $114-118B; rev. growth 19% to $196.2B.

META’s Q3 one-time tax charge: $15.93B, primarily from U.S. international tax reform.

My view: META has lost the momentum after the results. I will be cautiously adding to my position.

Amazon (AMZN)

Earnings per share: $1.95 vs. $1.57 estimate

Revenue: $180.17 billion vs. $177.8 billion estimated

Amazon Web Services: $33 billion vs. $32.42 billion expected

AWS revenue up +20% => first acceleration in over a year and highest growth rate since 2022

My view: Watch this sleeping giant for a turnaround.

Apple (AAPL)

• EPS: $1.85 vs. $1.77 estimated  
• Revenue: $102.47 billion vs. $102.24 billion estimated   
• iPhone revenue: $49.03 billion vs. $50.19 billion estimated.

My View: Apple did beat on all the front. My only concern has been “no major innovation”, neither on AI not on phone. It continues its luck based on its current installed base and affinity.

Netflix (NFLX) declared 10-1 stock split.

The earnings were OK, not great.

Palantir (PLTR)

Earnings per share: 21 cents vs. 17 cents expected

Revenues: $1.18 billion vs. $1.09 billion expected.

For the full year, Palantir now expects about $4.4 billion in sales, topping the $4.17 billion forecast.

My View: Palantir had a great quarter and great guidance. But the stock got hammered and I see it as a good opportunity. But valuations are still high. 

Advanced Micro Device (AMD)

Earnings per share of $1.20 on revenue of $9.25 billion. Analysts were anticipating EPS $1.17 on revenue of $8.74 billion.

My view: I liked the earnings. Today the company projected 35% revenue growth for next several years due to insatiable AI demand. Hence, it’s worth taking some position.

Aster Lab (ALAB)

49 cents a share on sales of $230.6 million in the September quarter. Analysts had expected earnings of 39 cents a share on sales of $206.5 million. On a year-over-year basis earnings was up 113% while sales climbed 104%.

A few Equity/Stocks to watch

• NVDA
• TSLA
• NBIS
• AMD
• APLD
• AVGO
• TEM
• CVNA
• SOXL
• TQQQ
• CRWV
• GOOG
• AMZN
• HIMS
• META
• MSFT
• SNOW
• PANW
• MDB
• DASH
• RDDT
• ENVX
• OPEN

Shesa’s Blog Portfolio (As of NOV 9, 2025)

Equity	Suggested Price	Current Price	Suggested Date	% Change	My View  (see disclaimer)
STOCK (All prices are in USD)
AAPL	12.9	268.47	1/25/13	1981%	Buy on Dip
META	47	621.71	11/13/13	1223%	Accumulate
MA	77.18	551.97	12/12/13	615%	HOLD
AMZN	15.58	216.37	4/12/14	1289%	Accumulate
SHOP	13.48	152.33	11/25/18	1030%	HOLD
SPG	54.59	183.6	5/25/20	236%	HOLD
NVDA	23.9	188.15	2/13/22	687%	Accumulate
TSLA	290.25	429.52	5/1/22	48%	Accumulate
RKT	14.24	16.16	7/6/25	13%	HOLD
SOXL	15.66	41.74	4/6/23	167%	Accumulate
GOOG	123.25	279.7	5/21/23	127%	Accumulate
PLTR	20.49	177.93	11/19/23	768%	Accumulate
PANW	142.06	212.29	3/31/24	49%	Buy on Dip
ENVX	10.48	9.56	4/28/24	-9%	HOLD
Z	51.92	73	8/11/24	41%	HOLD
LRCX	76.16	159.35	11/11/24	109%	Buy on Dip
RXRX	5.32	4.62	1/2/25	-13%	HOLD
IONQ	37.46	59.27	2/18/25	58%	Accumulate
AVGO	203.64	349.43	4/5/25	72%	Buy on Dip
APLD	11.18	30.98	6/15/25	177%	Accumulate
HOOD	94.4	130.36	7/6/25	38%	Accumulate
CRWV	104.14	104.01	8/3/25	-0%	Accumulate
NBIS	65.47	111.28	9/7/25	70%	Accumulate
HIMS	53.95	41.03	10/12/25	-24%	Accumulate
TEM	71.56	71.56	11/9/25	0%	NEW ADDITION
MUTUAL FUND
PRMTX	59.45	165.51	12/20/14	178%	HOLD
FSRPX	9.05	19.76	1/15/16	118%	HOLD

Equity Sold since my Last Blog

None

Here is my YouTube channel link:  https://www.youtube.com/channel/UCt7oLVUMG3NkJUzAVUzl4Tg

Disclaimer: This blog is meant to provide my opinion only. The information provided is to the best of my knowledge but may not be accurate. I do NOT provide any professional recommendation to buy/sell any stock, ETF, mutual fund, or any other security(s). As an investor, it’s your hard-earned money and you decide what is best for you. The above are merely my own opinions on what I do. Please contact a professional money manager to buy/sell any security. I do not charge any fees or commission by writing the blog except anything from Google AdSense. I have position(s) on whatever security I put on my blog portfolio and avoid including any security that I do not own or follow. Anyone buying or selling the equities mentioned here must do at their own risk.

Note: Click on Blog archives to read all my Blogs and updates.